Breast milk and hemp seed plus raw cannabis, side by side

Comparative Analysis: Adult Formula Breast Milk

Breast milk is the recognized gold standard of human nutrition. It is not merely adequate — it is architecturally optimized for the developing human, encoding millions of years of evolutionary pressure into a precise compositional profile. Nutritional science has used it as the benchmark for infant formula for this reason: it represents what biology intended.

One central finding is that hemp seed and raw Cannabis plant, taken together, match breast milk across the nutritional axes most relevant to ECS function — with a specificity that approaches the resolution of a Nutritional Facts label placed side by side. The comparison holds across:

Fatty acid profile: LA:ALA ratio, gamma-linolenic acid (GLA), stearidonic acid (SDA), and alpha-linolenic acid (ALA) — the upstream precursors from which the body synthesizes endocannabinoids
Acidic cannabinoid vitamers: CBDA, THCA, and CBGA, present in raw plant material and structurally analogous to vitamin precursors — biologically active in non-psychoactive form
Endocannabinoid precursor density: The substrate availability that enables NAPE-PLD, DAGL, and FAAH to maintain tone at AEA and 2-AG production

This work is deliberately positioned as food and nutrition science. It does not require pharmacological language, drug scheduling, or clinical trial infrastructure to establish its core claim. A cereal box can be compared to breast milk on a Nutritional Facts panel. So can hemp seed.

Breadcrumbs: Floyd & Benjamin, zenodo.org/records/19066408 (Pointedly Unresolved); zenodo.org/records/20437815 (Nutritional Gold Standard — Adult Formula)

Comparative lipid and signaling nutrient architecture: Human breast milk versus hemp seed + raw cannabis leaf/flower across twenty nutritional and ECS-related domains.

Component / Function	Human Breast Milk (Infant Formula)	Hemp Seed + Raw Cannabis Leaf/Flower (Adult Formula)
Primary fat content	3.5–4.5% total fat; ≈55% of calories; Rapid growth phase	30–35% total fat (seed); ~60% of calories; supplemented by raw leaf lipids; Maintenance phase
LA : ALA ratio (Omega-6 : Omega-3)	8–17:1 (modern Western) ~2–4:1 ancestral optimum	~2.5–3:1 — matches evolutionary optimum; balanced PUFA provides ideal ECS substrate availability
GLA (DGLA precursor)	Present in colostrum Declines postnatally	High: 1–4% of seed fat Anti-inflammatory bypass of rate-limiting enzymes → DGLA → PGE1; sustained supply via whole-plant consumption
SDA (EPA precursor)	Trace amounts	0.5–2%; Enhances EPA synthesis from ALA via Δ6-desaturase pathway
Arachidonic acid (ARA) 20:4 n-6	0.4–0.7% Pre-formed; direct availability	Synthesized on demand from LA via Δ6-desaturase + cofactors (Mg, Zn) supplied by seed
DHA 22:6 n-3	0.1–1.0% Pre-formed; maternally dependent; highly variable	Synthesized from ALA + SDA Mg/Zn cofactors provided; not pre-formed
Endocannabinoid precursors (2-AG / AEA substrate supply)	2-AG, AEA, PEA, OEA Present in μM range; direct	Optimal PUFA ratio for de novo synthesis → AA and ALA precursors Acidic cannabinoids support ECS tone directly
Direct endocannabinoid-like molecules (PEA, OEA)	PEA and OEA present in high amounts for gut/skin barrier; direct signaling	PEA/OEA homologues generated in vivo from raw plant ethanolamides and PUFA substrates
Endocannabinoid signaling	AEA and 2-AG present Regulates appetite, suckling reflex, and early neural signaling	CBDA, THCA, CBGA + fatty acid precursors Support ECS tone and downstream ethanolamide synthesis
Magnesium (Enzymatic cofactor)	30–35mg / L Cofactor for ECS enzymes and cAMP signaling; Optimized for infant bone	450–700mg / 100g seed Ample supply for NAPE-PLD, DAGL, and FAAH function; Δ6-desaturase cofactor + ECS enzyme support; Optimized for adult bone density & ATP
Zinc (Enzymatic cofactor)	1–3mg / L Receptor synthesis; enzymatic control; high in colostrum	9–12mg / 100g seed; essential cofactor in Δ6-desaturase conversion for PUFA elongation and ECS machinery; Exceeds breast milk density per gram of intake
Complete Protein [VALUES INVERTED FOR ADULT]	Casein + whey dominant Highly digestible; High IGF-1/Growth focus (mTOR activation, anabolic program); Complete amino acid profile	Edestin + Albumin; 85% bioavailability; PDCAAS comparable to animal protein; globulin-dominant, slow-digesting ratio optimized for adult homeostasis and regeneration (AMPK activation, maintenance program) — protein architecture is deliberately inverted relative to breast milk
L-Arginine Nitric oxide precursor	High arginine content Supports vascular ECS signaling downstream of ECS activation Infant blood flow, rapid tissue synthesis	Exceptionally high (14–17g / 100g protein); Strong nitric oxide precursor supply → ECS-vascular crosstalk; in adults feeds NO/ECS crosstalk axis for vascular homeostasis rather than growth
Phytosterols Membrane sterols	Cholesterol Myelination and membrane integrity in developing CNS	β-sitosterol + campesterol Optimize membrane order and rigidity; support GPCR (CB1/CB2) conformation; adult structural equivalent
Polyphenols / Tocopherols Antioxidant protection	Moderate flavonoids γ-tocopherol present	Very high γ-tocopherol (dominant form) Protects lipid substrates from peroxidation; preserves ECS precursor pool
Cannflavins / Flavonoids Anti-inflammatory compounds [VALUES INVERTED FOR ADULT]	Flavonoids (moderate activity); antioxidant role appropriate for the low systemic inflammatory load of a protected infant environment	Cannflavin A and B; ~30× more potent than aspirin at inhibiting PGE2-driven inflammation; scaled up anti-inflammatory capacity appropriate for the chronic inflammatory load of adult life — potency is deliberately inverted relative to breast milk
Prebiotic Fiber	Human milk oligosaccharides (HMOs) — prebiotic effect	Comparable profile (Hemp rhamnogalacturonans + soluble fiber) Supports gut microbiome; microbiome-ECS axis emerging
Anti-inflammatory lipid mediators	Series-1 and Series-3 dominant eicosanoids via ARA/DHA balance	Same outcome via GLA → DGLA → PGE1 pathway + SDA → EPA pathway; parallel series-3 eicosanoid support
Phospholipids / Membrane lipids	Phosphatidylcholine (PC) Phosphatidylethanolamine (PE) Sphingomyelin; essential for brain and cell membranes	Phospholipid fractions present in hemp seed High PUFA content supports dynamic membrane fluidity and GPCR function
Shared nutritional limitation	Vitamin B12 dependent Not synthesized; requires dietary or supplemental source	Vitamin B12 dependent Same dependency: neither the mother nor the plant makes B12. Milk carries it when the mother's intake is adequate; hemp seed does not. In both, it comes from outside the food — the single shared dependency across both substrates confirms structural validity of the infant-to-adult comparison

Primary fat content

3.5–4.5% total fat; ≈55% of calories;
Rapid growth phase

30–35% total fat (seed); ~60% of calories; supplemented by raw leaf lipids; Maintenance phase

LA : ALA ratio

(Omega-6 : Omega-3)

8–17:1 (modern Western)

~2–4:1 ancestral optimum

~2.5–3:1 — matches evolutionary optimum; balanced PUFA provides ideal ECS substrate availability

GLA (DGLA precursor)

Present in colostrum

Declines postnatally

High: 1–4% of seed fat

Anti-inflammatory bypass of rate-limiting enzymes → DGLA → PGE1; sustained supply via whole-plant consumption

SDA (EPA precursor)

Trace amounts

0.5–2%; Enhances EPA synthesis from ALA via Δ6-desaturase pathway

Arachidonic acid (ARA)

20:4 n-6

0.4–0.7%

Pre-formed; direct availability

Synthesized on demand from LA via

Δ6-desaturase + cofactors (Mg, Zn) supplied by seed

DHA

22:6 n-3

0.1–1.0%

Pre-formed; maternally dependent; highly variable

Synthesized from ALA + SDA

Mg/Zn cofactors provided; not pre-formed

Endocannabinoid precursors

(2-AG / AEA substrate supply)

2-AG, AEA, PEA, OEA

Present in μM range; direct

Optimal PUFA ratio for de novo synthesis → AA and ALA precursors

Acidic cannabinoids support ECS tone directly

Direct endocannabinoid-like

molecules (PEA, OEA)

PEA and OEA present in

high amounts for gut/skin barrier; direct signaling

PEA/OEA homologues generated in vivo from raw plant ethanolamides and PUFA substrates

Endocannabinoid signaling

AEA and 2-AG present

Regulates appetite, suckling reflex, and early neural signaling

CBDA, THCA, CBGA + fatty acid precursors

Support ECS tone and downstream ethanolamide synthesis

Magnesium

(Enzymatic cofactor)

30–35mg / L

Cofactor for ECS enzymes and cAMP signaling; Optimized for infant bone

450–700mg / 100g seed

Ample supply for NAPE-PLD, DAGL, and FAAH function; Δ6-desaturase cofactor + ECS enzyme support; Optimized for adult bone density & ATP

Zinc

(Enzymatic cofactor)

1–3mg / L

Receptor synthesis; enzymatic control; high in colostrum

9–12mg / 100g seed; essential cofactor in Δ6-desaturase conversion for PUFA elongation and ECS machinery; Exceeds breast milk density per gram of intake

Complete Protein

[VALUES INVERTED FOR ADULT]

Casein + whey dominant

Highly digestible; High IGF-1/Growth focus (mTOR activation, anabolic program); Complete amino acid profile

Edestin + Albumin; 85% bioavailability; PDCAAS comparable to animal protein; globulin-dominant, slow-digesting ratio optimized for adult homeostasis and regeneration (AMPK activation, maintenance program) — protein architecture is deliberately inverted relative to breast milk

L-Arginine

Nitric oxide precursor

High arginine content

Supports vascular ECS signaling downstream of ECS activation

Infant blood flow, rapid tissue synthesis

Exceptionally high (14–17g / 100g protein); Strong nitric oxide precursor supply → ECS-vascular crosstalk; in adults feeds NO/ECS crosstalk axis for vascular homeostasis rather than growth

Phytosterols

Membrane sterols

Cholesterol

Myelination and membrane integrity in developing CNS

β-sitosterol + campesterol

Optimize membrane order and rigidity; support GPCR (CB1/CB2) conformation; adult structural equivalent

Polyphenols / Tocopherols

Antioxidant protection

Moderate flavonoids

γ-tocopherol present

Very high γ-tocopherol (dominant form)

Protects lipid substrates from peroxidation; preserves ECS precursor pool

Cannflavins / Flavonoids

Anti-inflammatory compounds

[VALUES INVERTED FOR ADULT]

Flavonoids (moderate activity); antioxidant role appropriate for the low systemic inflammatory load of a protected infant environment

Cannflavin A and B; ~30× more potent than aspirin at inhibiting PGE2-driven inflammation; scaled up anti-inflammatory capacity appropriate for the chronic inflammatory load of adult life — potency is deliberately inverted relative to breast milk

Prebiotic Fiber

Human milk oligosaccharides

(HMOs) — prebiotic effect

Comparable profile (Hemp rhamnogalacturonans + soluble fiber)

Supports gut microbiome; microbiome-ECS axis emerging

Anti-inflammatory lipid mediators

Series-1 and Series-3 dominant

eicosanoids via ARA/DHA balance

Same outcome via GLA → DGLA → PGE1 pathway + SDA → EPA pathway; parallel series-3 eicosanoid support

Phospholipids / Membrane

lipids

Phosphatidylcholine (PC)

Phosphatidylethanolamine (PE)

Sphingomyelin; essential for brain and cell membranes

Phospholipid fractions present in hemp seed

High PUFA content supports dynamic membrane fluidity and GPCR function

Shared nutritional

limitation

Vitamin B12 dependent

Not synthesized; requires dietary or supplemental source

Vitamin B12 dependent

Same dependency: neither the mother nor the plant makes B12. Milk carries it when the mother's intake is adequate; hemp seed does not. In both, it comes from outside the food — the single shared dependency across both substrates confirms structural validity of the infant-to-adult comparison